NCT01496677View on ClinicalTrials.gov

Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 17, 2012

Primary Completion Date

February 28, 2012

Study Completion Date

February 28, 2012

Conditions
Healthy Subjects
Interventions
DRUG

TR-701 FA 200 mg

Single oral tablet of TR-701 FA to elderly subjects

DRUG

TR-701 FA 200 mg

Single oral tablet of TR-701 FA to younger group (18-45 years old)

Trial Locations (1)

32117

Trius Investigator Site 001, Daytona Beach

All Listed Sponsors
lead

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT01496677 - Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects | Biotech Hunter | Biotech Hunter